Logo image
Effects of testosterone treatment on bone mineral density in hypogonadal men receiving intrathecal opioids
Journal article   Open access   Peer reviewed

Effects of testosterone treatment on bone mineral density in hypogonadal men receiving intrathecal opioids

P.M. Finch, L.M. Price, P.T. Pullan and P.D. Drummond
Pain Practice, Vol.15(4), pp.308-313
2014
pdf
Effects_of_testosterone_treatment_on_bone_mineral_density.pdfDownloadView
Author’s Version Open Access
url
Link to Published Version *Subscription may be requiredView

Abstract

Background Opioid induced depression of sex hormones is a common finding in chronic pain patients receiving long-term opioids by oral, parenteral and even intrathecal routes of administration. The hypothalamic suppression by opioids leads to a hypogonadal state with low testosterone levels in males and subsequent low bone mineral density (BMD). Methods We have studied the effects of intrathecally administered opioids on BMD in a group of male chronic pain patients. In addition, we have studied the effects of supplementary testosterone on bone metabolism to see if the adverse effects of intrathecal opioids can be reversed. Results Eleven of the 27 patients were on supplementary testosterone having previously been diagnosed as hypogonadal with low serum testosterone. Duration of testosterone supplementation was greater than 2 years in all 11 patients. Both serum total and free testosterone levels were higher in patients on supplementary testosterone than in patients who did not receive this treatment. Of the 16 patients not on testosterone supplement, 14 (87%) had low serum testosterone levels (<10 nmol/L) and 11 (69%) had low or osteoporotic T scores. Within this group, low free testosterone was associated with low BMD scores, and this persisted after correcting for age. Eight of the patients on testosterone supplement had normal BMDT scores and three (27%) had low or osteoporotic T scores. T and age-corrected BMDZ scores were significantly greater in the 11 patients on testosterone supplements than BMD scores in the other 16 patients. Conclusion Testosterone supplementation was found to largely correct the effects of intrathecal opioids on testosterone levels and BMD.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

240 File views/ downloads
56 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.141 Hormone Therapy
1.141.1092 Testosterone and Steroids
Web Of Science research areas
Anesthesiology
Clinical Neurology
ESI research areas
Neuroscience & Behavior
Logo image